Skip to main content
Log in

The fate of praziquantel in the organism I. Pharmacokinetics in animals

  • Original Papers
  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

The pharmacokinetics of14C-praziquantel were tested in various species.

Intravenously injected praziquantel is rapidly absorbed by the tissues in all species. The sum of unchanged drug and metabolites is rapidly eliminated from the intravascular space at a half-life of 3 hours (phase I) and 8 hours (phase II). The elimination for praziquantel itself, however, is considerably shorter,i. e. about 1 hour.

After oral administration praziquantel was almost completely absorbed from the gastro-intestinal tract. Maximum serum concentrations were already reached within 30 min. to 1 hour. In rats absorption of the drug already from the stomach was observed.

Non-metabolised praziquantel shows—due to an intense first pass effect in the liver—only very low maximum serum concentrations.

All the species examined excrete the drug and its metabolites rapidly: within only 24 hours after administration the main portion of the administered14C-radioactivity was recovered in the excretion products. The kidneys are the predominant elimination path for praziquantel.

The percentage of radioactivity eliminated with the bile in rats was 37% of the dose within 7 hours after i. v. injection and 15% of the dose after oral administration.

Determination of the protein binding showed that 4/5 of the praziquantel is reversibly bound to serum proteins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Thomas, H. and Gönnert, R., Praziquantel, a new cestocide, Vet. Rec, submitted for publication.

  2. Faro, H. P. and Kunert, R., Praziquantel, synthesis andin vivo stability of the14C labelled drug, to be published.

  3. Diekmann, H. W. and Bühring, U. (1976), The fate of praziquantel in the organism. III. Metabolism in rat, Beagle-Dog and Rhesus-Monkey, to be published in this journal.

  4. Scholtan, W., Schlossmann, K. and Rosenkranz, H. (1966), Bestimmung der Eiweissbindung von Digitalis-Präpararaten mittels der Ultrazentrifuge. Arzneimittel-Forsch.,16, 106–118.

    Google Scholar 

  5. Dost, F. H. (1968), Grundlagen der Pharmakokinetik. Georg Thieme-Verlag, Stuttgart.

    Google Scholar 

  6. Steiner, K. and Garbe, A. (1976), The fate of praziquantel in the organism. II. Distribution in rats, to be published in this journal.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Steiner, K., Garbe, A., Diekmann, H.W. et al. The fate of praziquantel in the organism I. Pharmacokinetics in animals. European Journal of Drug Metabolism and Pharmacokinetics 1, 85–95 (1976). https://doi.org/10.1007/BF03189262

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03189262

Key-words

Navigation